Top Updates Back
Modalis Therapeutics Inc.
Modalis Therapeutics Corporation Alias
2016-01-01
Japan
CRISPR技術を用いた医薬品開発
プラットフォーム技術提供
エピゲノム編集技術を用いた遺伝子疾患治療薬開発
東京都中央区日本橋本町3-11-5 日本橋ライフサイエンスビルディング2 7F
森田 晴彦
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Editas Medicine, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Modalist Therapeutics Corporation
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
エディジーン株式会社(現株式会社モダリス)
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group

+ Loaded when opened
✅
2026-09-21 18:10 (Model: ggml-org/gpt-oss-20b )
↑